What first‑line antidepressant medication and dosing is recommended for a 14‑year‑old Asian boy with depression, including monitoring guidelines and alternative options?

First-Line Antidepressant for a 14-Year-Old Boy with Depression

Start fluoxetine 10 mg once daily as the first-line SSRI for this 14-year-old boy with moderate to severe depression, combined with cognitive behavioral therapy if available. 1, 2

Medication Selection and Rationale

Fluoxetine is the strongest evidence-based choice because:

• It is FDA-approved for depression in patients as young as 8 years old 2
• It has the most robust efficacy data in adolescents compared to other SSRIs 3
• Its long half-life provides a built-in buffer against withdrawal symptoms if doses are missed 1

Escitalopram is the only other FDA-approved option but requires the patient to be at least 12 years old (which this patient meets). Start at 10 mg daily if fluoxetine is not tolerated 1, 2.

Dosing Protocol

Starting dose: 10 mg once daily
Dose increments: Increase by 10-20 mg every 4-8 weeks based on response
Effective dose range: 20 mg daily
Maximum dose: 60 mg daily 1

Critical warning: Do NOT start at higher than recommended doses—this significantly increases the risk of deliberate self-harm and suicide-related events 1.

Monitoring Schedule

Week 1 (Ideally In-Person)

Assess for:

1. Ongoing depressive symptoms
2. Suicide risk (explicit questioning)
3. Adverse effects using a checklist
4. Treatment adherence
5. New environmental stressors 1

Weeks 2-8

• Contact weekly (telephone acceptable—evidence shows telephone monitoring is as reliable as in-person for adolescents) 1
• Focus on emergence of behavioral activation, agitation, or suicidality
• Monitor for switch to mania (irritability, decreased need for sleep, grandiosity)

After Week 8

• Continue monitoring every 2-4 weeks until stable
• Reassess treatment decision at 4-8 weeks if no improvement 2

Adverse Effects to Monitor

Inform patient and family about:

• Behavioral activation (restlessness, agitation, impulsivity)
• Suicidality (increased thoughts, plans, or attempts—particularly in first 4-8 weeks)
• Switch to mania (especially important given family history considerations)
• Common side effects: nausea, headache, insomnia, appetite changes 1

Treatment Duration

Continue medication for at least 1 year after response to prevent relapse—the greatest relapse risk occurs in the first 8-12 weeks after discontinuation 1. This is based on controlled trial data showing significantly fewer relapses with extended maintenance treatment 1.

When to Modify Treatment (4-8 Weeks)

If inadequate response after 4-8 weeks at therapeutic dose:

1. Switch to a different SSRI (escitalopram, sertraline, or citalopram) 1
2. Add cognitive behavioral therapy if not already included 4
3. Consider consultation with child psychiatry 1

Combination Therapy Consideration

For moderate to severe depression, strongly consider combining fluoxetine with cognitive behavioral therapy from the start—evidence shows superior outcomes compared to either treatment alone 2, 4. This is a strong recommendation based on multiple controlled trials.

Asian Population Considerations

Data from Asian psychiatric centers show fluoxetine, sertraline, and escitalopram are the most commonly prescribed antidepressants in this age group 5. No specific dosing adjustments are required based on ethnicity alone, but monitor closely as with any patient.

Common Pitfalls to Avoid

• Starting at too high a dose increases suicide risk 1
• Inadequate monitoring frequency in first 8 weeks—this is when adverse events peak
• Stopping medication too soon after response—maintain for full year 1
• Abrupt discontinuation rather than gradual taper (risk of withdrawal syndrome) 6
• Failing to assess for bipolar family history before starting—SSRIs can trigger mania 7

Contraindications

Do not use with monoamine oxidase inhibitors (MAOIs) 1.